This is a preview of subscription content, log in via an institution to check access.
Notes
Thai baht
Reference
Sangroongruangsri S, et al Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand. ClinicoEconomics and Outcomes Research : 12 Nov 2021. Available from: URL: https://doi.org/10.2147/CEOR.S340570
Rights and permissions
About this article
Cite this article
Ranibizumab, aflibercept not cost effective for polypoidal choroidal vasculopathy in Thailand. PharmacoEcon Outcomes News 892, 20 (2021). https://doi.org/10.1007/s40274-021-08215-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08215-z